Overall, the results of this study indicate that LY3437943 has a safety and tolerability profile similar to other incretins, with pharmacokinetic and pharmacodynamic outcomes that support further clinical evaluation
On a relative cost basis in 2026, semaglutide is the lower-cost option among the authorised compounds, with tirzepatide reported as roughly 2030% more expensive [2] [unverified]
The difference is 2.3 percentage points
In the clinical trial with pediatric patients receiving metformin HCl immediate-release tablets, adverse reactions with metformin HCl immediate-release tablets were similar to those described in adults [see ADVERSE REACTIONS ]
XIGDUO XR may cause serious side effects including: See What is the most important information I should know about XIGDUO XR?
Intramuscular injection can cause increased pain, faster drug absorption than intended, and a higher risk of bruising